Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
all decrease » small decrease (Expand Search), fold decrease (Expand Search), awd decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
all decrease » small decrease (Expand Search), fold decrease (Expand Search), awd decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
2261
-
2262
-
2263
-
2264
-
2265
-
2266
-
2267
Regional differences in percentage changes of N06A prescribing rates during the pandemic.
Published 2025Subjects: -
2268
(a) Comparison of the approximate solution X(x,y) with the exact solution of the problem 3.
Published 2025Subjects: -
2269
-
2270
-
2271
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Furthermore, compound <b>E35</b> showed an obvious inhibitory effect on MGC-803 xenograft mice without obvious toxicity. All of these results suggest that compound <b>E35</b> might be a valuable lead compound for antitumor agents targeting Skp2.…”
-
2272
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Furthermore, compound <b>E35</b> showed an obvious inhibitory effect on MGC-803 xenograft mice without obvious toxicity. All of these results suggest that compound <b>E35</b> might be a valuable lead compound for antitumor agents targeting Skp2.…”
-
2273
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Furthermore, compound <b>E35</b> showed an obvious inhibitory effect on MGC-803 xenograft mice without obvious toxicity. All of these results suggest that compound <b>E35</b> might be a valuable lead compound for antitumor agents targeting Skp2.…”
-
2274
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Furthermore, compound <b>E35</b> showed an obvious inhibitory effect on MGC-803 xenograft mice without obvious toxicity. All of these results suggest that compound <b>E35</b> might be a valuable lead compound for antitumor agents targeting Skp2.…”
-
2275
Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer
Published 2024“…Furthermore, compound <b>E35</b> showed an obvious inhibitory effect on MGC-803 xenograft mice without obvious toxicity. All of these results suggest that compound <b>E35</b> might be a valuable lead compound for antitumor agents targeting Skp2.…”
-
2276
-
2277
-
2278
IRE1 silencing downregulates cell cycle genes and engages TP53 and specific CDK inhibitors.
Published 2025Subjects: -
2279
-
2280